microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma.

Lin, Ruey-Jen; Lin, You-Chin; Chen, Jeremy; Kuo, Huan-Hsien; Chen, Yuan-Yan; Diccianni, Mitchell B; London, Wendy B; Chang, Chih-Hao; Yu, Alice L

Lin, Ruey-Jen; Lin, You-Chin; Chen, Jeremy; Kuo, Huan-Hsien; Chen, Yuan-Yan; Diccianni, Mitchell B; London, Wendy B; Chang, Chih-Hao; Yu, Alice L.

Affiliation

Lin RJ; Graduate Institute of Life Science, National Defense Medical Center, and Genomics Research Center, Academia Sinica, Taipei, Taiwan.

Cancer Res ; 70(20): 7841-50, 2010 Oct 15.

Article in En | MEDLINE | ID: mdl-20805302

Subject(s)

Gene Silencing; MicroRNAs/genetics; Neuroblastoma/genetics; Ribonuclease III/genetics; Cell Line, Tumor; Colony-Forming Units Assay; DNA Primers; Gene Expression; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Neuroblastoma/enzymology; Neuroblastoma/epidemiology; Plasmids; Polymerase Chain Reaction/methods; Predictive Value of Tests; Prognosis; RNA, Messenger/genetics; RNA, Neoplasm/genetics; Ribonuclease III/deficiency; Risk Assessment; Transfection

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Silencing / MicroRNAs / Ribonuclease III / Neuroblastoma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Res Year: 2010 Type: Article Affiliation country: Taiwan

Fulltext

XML

PubMed Links

Search on Google